Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34878 | 60 | 20.6 | 39% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SLOWLY PROGRESSIVE DIABETES | Author keyword | 2 | 67% | 3% | 2 |
2 | ULTRALOW DOSES | Author keyword | 2 | 25% | 10% | 6 |
3 | ANAFERON PEDIATRIC FORMULATION | Author keyword | 1 | 33% | 5% | 3 |
4 | BIOL PATHOL PANCREAS ENDOCRINE B2PE | Address | 1 | 50% | 2% | 1 |
5 | BIPATHIC EFFECT | Author keyword | 1 | 50% | 2% | 1 |
6 | OCEAN MARINE SCI | Address | 1 | 50% | 2% | 1 |
7 | UNITE BFA BIOL FONCT AD T | Address | 1 | 50% | 2% | 1 |
8 | VECTOR VIROL BIOTECHNOL | Address | 1 | 50% | 2% | 1 |
9 | WISTAR RAT BRAIN | Author keyword | 1 | 50% | 2% | 1 |
10 | ACUTE RESPIRATORY VIRAL INFECTION | Author keyword | 0 | 33% | 2% | 1 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SLOWLY PROGRESSIVE DIABETES | 2 | 67% | 3% | 2 | Search SLOWLY+PROGRESSIVE+DIABETES | Search SLOWLY+PROGRESSIVE+DIABETES |
2 | ULTRALOW DOSES | 2 | 25% | 10% | 6 | Search ULTRALOW+DOSES | Search ULTRALOW+DOSES |
3 | ANAFERON PEDIATRIC FORMULATION | 1 | 33% | 5% | 3 | Search ANAFERON+PEDIATRIC+FORMULATION | Search ANAFERON+PEDIATRIC+FORMULATION |
4 | BIPATHIC EFFECT | 1 | 50% | 2% | 1 | Search BIPATHIC+EFFECT | Search BIPATHIC+EFFECT |
5 | WISTAR RAT BRAIN | 1 | 50% | 2% | 1 | Search WISTAR+RAT+BRAIN | Search WISTAR+RAT+BRAIN |
6 | ACUTE RESPIRATORY VIRAL INFECTION | 0 | 33% | 2% | 1 | Search ACUTE+RESPIRATORY+VIRAL+INFECTION | Search ACUTE+RESPIRATORY+VIRAL+INFECTION |
7 | DIFFERENT TIMES | 0 | 33% | 2% | 1 | Search DIFFERENT+TIMES | Search DIFFERENT+TIMES |
8 | INBRED BB | 0 | 33% | 2% | 1 | Search INBRED+BB | Search INBRED+BB |
9 | RELEASE ACTIVITY | 0 | 33% | 2% | 1 | Search RELEASE+ACTIVITY | Search RELEASE+ACTIVITY |
10 | ANTIBODIES TO INTERFERON | 0 | 25% | 2% | 1 | Search ANTIBODIES+TO+INTERFERON | Search ANTIBODIES+TO+INTERFERON |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ANAFERON PEDIATRIC FORMULATION | 1 | 100% | 3% | 2 |
2 | FATTY OLETF STRAIN | 1 | 50% | 2% | 1 |
3 | MOLECULAR PATHOGENIC MECHANISMS | 1 | 50% | 2% | 1 |
4 | FUSION ANTIBODY | 0 | 33% | 2% | 1 |
5 | KK TA MOUSE | 0 | 33% | 2% | 1 |
6 | HEPATIC CHANGES | 0 | 20% | 2% | 1 |
7 | SEXUAL INCENTIVE MOTIVATION | 0 | 17% | 2% | 1 |
8 | ERGOFERON | 0 | 100% | 2% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Animal models of diabetes mellitus | 2005 | 216 | 112 | 2% |
Animal models in glucose intolerance and type-2 diabetes | 2007 | 0 | 50 | 4% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | BIOL PATHOL PANCREAS ENDOCRINE B2PE | 1 | 50% | 1.7% | 1 |
2 | OCEAN MARINE SCI | 1 | 50% | 1.7% | 1 |
3 | UNITE BFA BIOL FONCT AD T | 1 | 50% | 1.7% | 1 |
4 | VECTOR VIROL BIOTECHNOL | 1 | 50% | 1.7% | 1 |
5 | PHYSIOL HIGHER NERVOUS ACT | 0 | 18% | 3.3% | 2 |
6 | MATERIA MED HOLDING | 0 | 100% | 1.7% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191523 | APA HAMSTER//APA HAMSTERS//ATHEROMATOUS LESION |
2 | 0.0000152592 | PHOSPHOLIPIDS COMPOSITION//LIVER INDEX//AGING ASSOCIATED DISEASES |
3 | 0.0000152290 | CHILDREN NEUROSURG//ELECTROPATHOLOGY//EMBRYONIC NERVOUS TISSUE |
4 | 0.0000131959 | SDT FATTY RAT//SDT RAT//PLANNING DEV SECT |
5 | 0.0000099948 | D GLUCOSE METABOLISM//SUCCINIC ACID DIMETHYL ESTER//EXPT HORMONOL |
6 | 0.0000096142 | ACHYRANTHES ASPERA//ARGYREIA SPECIOSA//FICUS THONNINGII |
7 | 0.0000093447 | ALLOXAN RADICAL//ALLOXAN//BIOCHEM IMMUNE SYST |
8 | 0.0000074967 | PSAMMOMYS OBESUS//EXPLORATORY TOXICOL DMPK//NUTRITIONAL DIABETES |
9 | 0.0000074671 | WEAK MAGNETIC FIELDS//CATHOLYTE//DIAPHRAGM ELECTROLYZER |
10 | 0.0000072696 | ASPERGILLUS TERREUS IFO 6123//ASTERRIQUINONE//2 3 DIHYDROBENZOBFURAN |